Vectura Group Share Price (VEC)

78.93 -2.27 (-2.80%) delayed: 8:42AM GMT
Bid price 78.85 Open price 81.15
Ask price 79.00 Prev close 81.20
High price 81.33 Spread 0.19%
Low price 78.85 Volume 204,744

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc is an industry-leading device and formulation business for inhaled airways products offering a uniquely integrated inhaled drug delivery platform. With its extensive range of device and formulation technologies, integrated capabilities and collaborations, it is a leader in the development of inhalation products, increasing its ability to help patients suffering from respiratory diseases. Vectura has eight inhaled, four non-inhaled and ten oral products marketed by partners with growing global royalty streams. The Group has a diverse portfolio of drugs in clinical development, including a number of novel and generic programmes which are partnered with several global pharmaceutical and biotechnology companies including Hikma, Novartis, Sandoz, Mundipharma, Kyorin, Baxter, GSK, UCB, Ablynx, Grifols, Bayer, Chiesi, Almirall, Janssen, Dynavax and Tianjin KingYork along with two wholly owned nebulised development. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 78.93 Net Gearing (%) 9.01
Market Capitalisation (£m) 539.03 Gross Gearing (%) 19.94
Shares in issue (m) 663.83 Debt Ratio 12.69
P/E Ratio -15.32 Debt-to-Equity Ratio 0.58
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.25
Dividend Yield (%) 0.00 Price to book value 0.80
Dividend cover (x) 0.00 ROCE (%) -5.17
Earning per share (p) -5.30 EPS Growth (%) -541.67
52 week high / low 166.90 / 70.15 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
15/02/2018 BUY Andrew Derodra FD 211
18/01/2018 BUY Andrew Derodra FD 127
12/12/2017 BUY Andrew Derodra FD 153
09/11/2017 BUY Andrew Derodra FD 156
10/10/2017 BUY Andrew Derodra FD 142

More Vectura Group Director Deals >>

Vectura Group Company News

16:52 12/03/2018

FTSE hit by surge in pound on Brexit transition deal reports

The FTSE 100 fell into the red on the back of the stronger pound following reports the UK is nearing a transition deal with the European Union. The stronger sterling had a negative impact as the majority of blue-chip earnings come from overseas, leaving the FTSE 0.1% lower at 7,214. House...

13:49 12/03/2018

Hikma Pharmaceutical loses dispute with FDA over asthma treatment

Hikma Pharmaceutical said a dispute resolution against the US Food and Drug Administration about the delayed launch of generic asthma treatment, VR315, had failed. The company said it now anticipated new clinical data for the treatment to be submitted 'as early as possible in 2019.' 'Hikma...

11:55 12/03/2018

FTSE flat on weaker miners

The FTSE 100 was up only 10.5 points at 7,235 as weakness in housebuilders and miners threatened to offset a strong performance from insurance stocks. House prices in London declined by up to 15% over the last year due to volatility from the Brexit vote, according to Your Move. Brent crude oil...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

more than 1 year ago


Powered by IST's

Register now for FREE Vectura Group share price discussions